In mouse tumor cells, 901 substantially inhibited the phosphorylation of ERK1/2 and slightly inhibited the mRNA expression of YAP/TAZ but not their downstream target genes CTGF and Cyr61 (Figure 7A). The gene discussed is MAPK3; the disease is neoplasm.